Xpert® Bladder Cancer Detection

Home / Tests / Oncology & Human Genetics

Detection of the presence of bladder cancer in patients with hematuria in around 90 minutes

Test pack size(s)

10 Tests

GXBLAD-CD-CE-10

Qty

Unit price

Subtotal

USD

$0.00

Collection devices

Kit, Xpert Urine Transport Reagent Kit (30 Collection Devices)

GXUTR-CE-30

Qty

Unit price

Subtotal

USD

$0.00

Total

$0.00

The Need

Early and accurate diagnosis of bladder cancer is critical in patients with hematuria.³

Four out of five people with bladder cancer have blood in their urine⁴
But 80–90% of patients with visible hematuria, and over 95% of patients with non-visible hematuria do NOT have cancer
There are many known causes of hematuria including urinary tract infection, nephrolitiasis (stones), etc⁴
In patients with hematuria, it can be difficult to decide which patients might have cancer and which patients might have a different condition
Primary care physicians are sometimes reluctant to refer patients with visible or significant microscopic hematuria to urology for further investigation⁵

3 Kamat AM, et al. Bladder Cancer. Lancet. 2016 Dec 3;388(10061):2796-2810.
4 Avellino G, et al. Diagnosis and Management of hematuria. Surg Clin North Am. 2016 Jun;96(3): 503-15.
5 Yafi FA, et al. Patients with microscopic and gross hematuria: practice and referral patterns among primary care physicians in a universal health care system. Can Urol Assoc J 2011;5(2):97-101.

The Solution

Xpert Bladder Cancer Detection is a non-invasive biomarker test for patients with hematuria that is used in conjunction with other clinical measures.

Five mRNA biomarkers were intensively validated for the detection of bladder cancer
The non-invasive and painless test uses voided urine samples
The test is performed using a self-contained cartridge and system, and can be performed in any size urology lab
Each cartridge contains three controls for dependable results
Sample stability for up to 7 days in Xpert® Urine Transport Reagent
The test enables flexible testing as require

The Impact

A test that helps clinicians gain additional information for patients with hematuria.

Non-invasive test to reduce patients’ anxiety, pain, and embarrassment⁶
High negative predictive value may help patients avoid unnecessary procedures and discomfort⁷
Easy to implement and train
Robust test and workflow with decentralized laboratory testing

6 Biardeau X, et al. Prospective evaluation of anxiety, pain, and embarrassment associated with cystoscopy and urodynamic testing in clinical practice. Can Urol Assoc J. 2017 Mar-Apr; 11(3-4): 104–110.
7 Todenhöfer, et al. Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer. BMC Cancer. 2015 Mar 19;15:155.